Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 133

Results For "NCEs"

2682 News Found

Sequent Scientific receives WHO prequalification approval for Albendazole API
News | August 20, 2024

Sequent Scientific receives WHO prequalification approval for Albendazole API

This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation


Health Minister Nadda reviews Monkeypox situation and preparedness
Policy | August 19, 2024

Health Minister Nadda reviews Monkeypox situation and preparedness

Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management


CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance
News | August 19, 2024

CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance

The emergence of new infections in India is a growing concern


Wanbury appoints Prakash Venkatraman as President of API Business
People | August 14, 2024

Wanbury appoints Prakash Venkatraman as President of API Business

He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years


NHA and MUHS sign MoU to drive digital health education
News | August 14, 2024

NHA and MUHS sign MoU to drive digital health education

The partnership marks a significant milestone in integrating digital health education into medical curricula


Ashland completes second expansion of Viatel bioresorbable polymers manufacturing and R&D lab in Ireland
News | August 13, 2024

Ashland completes second expansion of Viatel bioresorbable polymers manufacturing and R&D lab in Ireland

This project is supported by the Irish Government through IDA Ireland


Morepen Labs Q1 FY25 profit surges 147% to Rs. 36.17 Cr
News | August 13, 2024

Morepen Labs Q1 FY25 profit surges 147% to Rs. 36.17 Cr

Morepen Labs successfully raised Rs. 200 Crore through QIP


Zydus receives final approval from USFDA for Valbenazine Capsules
Drug Approval | August 11, 2024

Zydus receives final approval from USFDA for Valbenazine Capsules

Valbenazine Capsules had annual sales of US $1,993.6 mn in the United States (IQVIA MAT June 2024)


Merck inks MoU with Aragen to facilitate supply of equipment and technologies for mAb
News | August 11, 2024

Merck inks MoU with Aragen to facilitate supply of equipment and technologies for mAb

This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule